Quantinno Capital Management LP Purchases 13,698 Shares of The Ensign Group, Inc. $ENSG

Quantinno Capital Management LP increased its position in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 137.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,683 shares of the company’s stock after acquiring an additional 13,698 shares during the quarter. Quantinno Capital Management LP’s holdings in The Ensign Group were worth $4,772,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Baillie Gifford & Co. increased its position in The Ensign Group by 62.1% in the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after purchasing an additional 1,750,645 shares during the period. Norges Bank acquired a new position in The Ensign Group during the 4th quarter valued at about $134,660,000. Turtle Creek Asset Management Inc. bought a new position in shares of The Ensign Group in the 3rd quarter valued at about $78,840,000. Wasatch Advisors LP boosted its stake in shares of The Ensign Group by 6.0% in the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares during the last quarter. Finally, Candriam S.C.A. grew its position in shares of The Ensign Group by 264.9% during the 1st quarter. Candriam S.C.A. now owns 259,917 shares of the company’s stock worth $52,373,000 after buying an additional 188,679 shares during the period. Institutional investors own 96.12% of the company’s stock.

Insider Transactions at The Ensign Group

In other news, Director Barry M. Smith sold 700 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares of the company’s stock, valued at $3,507,706.56. This represents a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the transaction, the director directly owned 9,503 shares of the company’s stock, valued at $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by corporate insiders.

The Ensign Group Stock Performance

Shares of ENSG opened at $181.66 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The firm’s 50 day moving average price is $166.34 and its two-hundred day moving average price is $183.97. The firm has a market cap of $10.59 billion, a P/E ratio of 28.47, a PEG ratio of 1.72 and a beta of 0.68.

The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter in the prior year, the company earned $1.59 earnings per share. The business’s quarterly revenue was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, analysts forecast that The Ensign Group, Inc. will post 6.93 EPS for the current fiscal year.

The Ensign Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Tuesday, June 30th. The Ensign Group’s dividend payout ratio is 4.08%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ENSG shares. Royal Bank Of Canada reissued an “outperform” rating and set a $228.00 price target on shares of The Ensign Group in a research note on Tuesday, July 28th. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a research note on Saturday, July 25th. Finally, Truist Financial raised their price target on The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research report on Thursday, July 30th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $216.25.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.